Company Search:
Advanced Search
Sponsored Links
Alkaloid AD Skopje Company Snapshot
Alkaloid AD Skopje operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alkaloid AD Skopje with three other pharmaceutical manufacturers in Europe: Eckert & Ziegler Strahlen- und Medizinte of GERMANY (2019 sales of 178.49 million Euros [US$196.36 million] of which 59% was Isotope Products), Deva Holding AS of TURKEY (1.37 billion Turkish Liras [US$202.84 million] of which 93% was Pharmaceuticals), and Karo Pharma AB which is based in SWEDEN (1.90 billion Swedish Kronor [US$197.52 million] of which 100% was Drugs Discovery & Dev).

Sales Analysis. Alkaloid AD Skopje reported sales of 11.10 billion Macedonian Denars (US$198.30 million) for the year ending December of 2019. This represents an increase of 13.5% versus 2018, when the company's sales were 9.78 billion Macedonian Denars. Sales at Alkaloid AD Skopje have increased during each of the previous five years (and since 2014, sales have increased a total of 50%). Sales of Botanicals saw an increase that was more than double the company's growth rate: sales were up 41.0% in 2019, from 291.74 million Macedonian Denars to 411.38 million Macedonian Denars. Not all segments of Alkaloid AD Skopje experienced an increase in sales in 2019: sales of Cosmetics fell 2.3% to 878.22 million Macedonian Denars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Alkaloid AD Skopje
  Stock Performance Chart for Alkaloid AD Skopje
  Stock Data: Recent Stock Performance:
  Current Price (5/29/2020): 12,300
(Figures in Macedonian Denars)
1 Week -1.6%   13 Weeks -1.6%  
4 Weeks -3.9%   52 Weeks 35.1%  
Alkaloid AD Skopje Key Data:
  Ticker: ALK Country: Macedonia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 11,102,808,000
(Year Ending Jan 2020).
Employees: 2,227
  Currency: Macedonian Denars Market Cap: 17,338,030,800
  Fiscal Yr Ends: December Shares Outstanding: 1,409,596
  Share Type: Closely Held Shares: 122,238
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.